BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632 [PMID: 25848487 DOI: 10.4254/wjh.v7.i3.628]
URL: https://www.wjgnet.com/1007-9327/full/v7/i3/628.htm
Number Citing Articles
1
Pablo Lozano Lominchar, Maitane Igone Orue-Echebarria, Lorena Martín, Cristina Julia Lisbona, María Magdalena Salcedo, Luis Olmedilla, Hemant Sharma, Jose Manuel Asencio, José Ángel López-Baena. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort studyWorld Journal of Hepatology 2019; 11(9): 689-700 doi: 10.4254/wjh.v11.i9.689
2
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo. Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolizationJournal of the Formosan Medical Association 2021;  doi: 10.1016/j.jfma.2021.07.003
3
D. J. Pinato, J. Howell, R. Ramaswami, R. Sharma. Review article: delivering precision oncology in intermediate-stage liver cancerAlimentary Pharmacology & Therapeutics 2017; 45(12): 1514 doi: 10.1111/apt.14066
4
Wen-xin Wei, Zhi-shi Yang, Li-hua Lu, Jun Li, Zheng-qing Lei, Kui Wang, Yong Xia, Zhen-lin Yan, Feng Shen. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinomaInternational Journal of Surgery 2018; 56: 256 doi: 10.1016/j.ijsu.2018.06.020
5
Larisse Longo, Laura B. Rodrigues de Freitas, Deivid Santos, Ivana Grivicich, Mário R. Álvares-da-Silva. BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular CarcinomaAmerican Journal of Clinical Oncology 2019; 42(5): 466 doi: 10.1097/COC.0000000000000539
6
Peng-Sheng Yi, Hong Wang, Jian-Shui Li. Evolution and current status of the subclassification of intermediate hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2020; 12(3): 85-92 doi: 10.4240/wjgs.v12.i3.85
7
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCCMicrobial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
8
Leandro Armani Scaffaro, Cleber Dario Pinto Kruel, Steffan Frosi Stella, Gabriela Leal Gravina, Geraldo Machado Filho, Carlos Podalirio Borges de Almeida, Luiz Cezar Pontes Fonseca Pinto, Mario Reis Alvares-da-Silva, Cleber Rosito Pinto Kruel. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and MicrospheresBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/435120
9
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substageEuropean Journal of Nuclear Medicine and Molecular Imaging 2019; 46(3): 661 doi: 10.1007/s00259-018-4152-7
10
Sangheun Lee, Beom Kyung Kim, Kijun Song, Jun Yong Park, Sang Hoon Ahn, Seung Up Kim, Kwang-Hyub Han, Do Young Kim. Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry databaseJournal of Gastroenterology and Hepatology 2016; 31(4): 842 doi: 10.1111/jgh.13218
11
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinomaTherapeutic Advances in Medical Oncology 2020; 12: 175883592097084 doi: 10.1177/1758835920970840
12
Wei Xu, Quan Rao, Yongbo An, Mengyi Li, Gang Xu, Xinting Sang, Xin Lu, Zhongtao Zhang, Yilei Mao. Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child–Pugh A liver functionMedicine 2018; 97(32): e11800 doi: 10.1097/MD.0000000000011800
13
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21